Market Research Logo

Nuo Therapeutics Inc (NUOTQ) - Financial and Strategic SWOT Analysis Review

Nuo Therapeutics Inc (NUOTQ) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Nuo Therapeutics Inc (Nuo Therapeutics) is a biomedical company, which specializes in biodynamic therapies in the area of wound care. It focuses on commercializing cell-based technologies, which bind the regenerative capacity of the human body to trigger natural healing. The company's flagship product, Aurix System, is a biodynamic hematogel designed to harness a patient's innate regenerative abilities to manage a wide range of wounds. Aurix is US FDA approved platelet and plasma therapy system for managing a wide range of ulcers and exuding wounds, including leg ulcer, diabetic ulcer, pressure ulcer, and all severities such as full thickness, partial thickness and complex wounds. The company has an office in Nashville, Tennessee; and a facility in Durham, North Carolina. Nuo Therapeutics is headquartered in Gaithersburg, Maryland, the US.

Nuo Therapeutics Inc Key Recent Developments


Mar 29,2016: Nuo Therapeutics Provides Update on Chapter 11 Bankruptcy Process and Proposed Plan of Reorganization
Jan 26,2016: Nuo Therapeutics Commences Voluntary Chapter 11 Business Reorganization
Jan 12,2016: Nuo Therapeutics Announces Senior Management Change and Provides Limited Corporate Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company 5
Nuo Therapeutics Inc - Key Facts 5
Nuo Therapeutics Inc - Key Employees 6
Nuo Therapeutics Inc - Key Employee Biographies 7
Nuo Therapeutics Inc - Major Products and Services 8
Nuo Therapeutics Inc - History 9
Nuo Therapeutics Inc - Company Statement 11
Nuo Therapeutics Inc - Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 13
Nuo Therapeutics Inc - Business Description 13
Nuo Therapeutics Inc - Corporate Strategy 14
Nuo Therapeutics Inc - SWOT Analysis 15
SWOT Analysis - Overview 15
Nuo Therapeutics Inc - Strengths 15
Nuo Therapeutics Inc - Weaknesses 16
Nuo Therapeutics Inc - Opportunities 17
Nuo Therapeutics Inc - Threats 18
Nuo Therapeutics Inc - Key Competitors 19
Section 3 – Company Financial Ratios 20
Financial Ratios - Capital Market Ratios 20
Financial Ratios - Annual Ratios 21
Performance Chart 23
Financial Performance 23
Financial Ratios - Interim Ratios 24
Financial Ratios - Ratio Charts 25
Section 4 – Company’s Lifesciences Financial Deals and Alliances 26
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27
Nuo Therapeutics Inc, Recent Deals Summary 28
Section 5 – Company’s Recent Developments 29
Mar 29, 2016: Nuo Therapeutics Provides Update on Chapter 11 Bankruptcy Process and Proposed Plan of Reorganization 29
Jan 26, 2016: Nuo Therapeutics Commences Voluntary Chapter 11 Business Reorganization 31
Jan 12, 2016: Nuo Therapeutics Announces Senior Management Change and Provides Limited Corporate Update 32
Section 6 – Appendix 33
Methodology 33
Ratio Definitions 33
About GlobalData 37
Contact Us 37
Disclaimer 37
List of Tables
Nuo Therapeutics Inc, Key Facts 5
Nuo Therapeutics Inc, Key Employees 6
Nuo Therapeutics Inc, Key Employee Biographies 7
Nuo Therapeutics Inc, Major Products and Services 8
Nuo Therapeutics Inc, History 9
Nuo Therapeutics Inc, Other Locations 12
Nuo Therapeutics Inc, Subsidiaries 12
Nuo Therapeutics Inc, Key Competitors 19
Nuo Therapeutics Inc, Ratios based on current share price 20
Nuo Therapeutics Inc, Annual Ratios 21
Nuo Therapeutics Inc, Annual Ratios (Cont...1) 22
Nuo Therapeutics Inc, Interim Ratios 24
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27
Nuo Therapeutics Inc, Recent Deals Summary 28
Currency Codes 33
Capital Market Ratios 33
Equity Ratios 34
Profitability Ratios 34
Cost Ratios 35
Liquidity Ratios 35
Leverage Ratios 36
Efficiency Ratios 36
List of Figuress
Nuo Therapeutics Inc, Performance Chart (2012 - 2016)
Nuo Therapeutics Inc, Ratio Charts
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report